Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745237 · ClinicalTrials.gov registry record
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
A clinical trial of Sarcoidosis, sponsored by Duke University.
- Recruiting
- Registry status
- 27,000
- Enrollment target
- 1
- Study location
NCT01745237 is a study of Sarcoidosis that is actively recruiting participants, run by Duke University. The registered enrollment target is 27,000 participants, above the 884-participant average among 21 other Sarcoidosis trials with a reported enrollment target (2954% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01745237, a study of Sarcoidosis, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 27,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,000 participants |
| Start Date | 2002-09 |
| Est. Completion | 2032-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01745237
The ClinicalTrials.gov registry entry for NCT01745237 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 27,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 884-participant average among 21 other Sarcoidosis trials with a reported enrollment target (2954% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcoidosis appearing as the primary indexed condition, and to 0 interventions.
NCT01745237 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01745237 about?
NCT01745237 is a clinical study titled "Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis". The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
What is the current status of trial NCT01745237?
This trial is currently recruiting. The enrollment target is 27,000 participants. The study started on 2002-09. Estimated completion is 2032-06.
What conditions does trial NCT01745237 study?
This clinical trial studies the following conditions: Sarcoidosis.
Who is sponsoring clinical trial NCT01745237?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01745237 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
RECRUITING
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Cardiac Sarcoidosis Randomized Trial
RECRUITING · Phase 3
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
Vitamin D Homeostasis in Sarcoidosis
RECRUITING · Phase 4
-
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.